Research demonstrates effective opioid use disorder treatment with extended-release buprenorphine during pregnancy, suggesting better outcomes for mothers and babies.
A landmark study supporting weekly extended‐release buprenorphine for opioid use disorder (OUD) treatment during pregnancy was published in JAMA Internal Medicine online March 16.
No takes yet. Share an insight, caveat, or question.
Alison Knopf (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: